top of page
About
Our Company
Our Leadership Team
Science
Our Technology
DNA Methylation
Exosomes
Products
Our Portfolio
Laboratory Developed Tests Services
Eye Care
Clinical Trial Drug Distribution
Health Supplements
Pipeline
Newsroom
Contact
Investors
More
Use tab to navigate through the menu items.
Newsroom
All Posts
Publication
News
Leadership Story
YD Bio Expands U.S. Laboratory Footprint to 47 States, Strengthening DNA-Methylation Early Cancer Detection Operations
Jul 8
YD Bio Limited Reports Full Year 2025 Financial Results
May 7
YD Bio and EG BioMed Launch Nationwide Telehealth Platform to Expand Cancer Detection Services in the U.S.
Apr 2
YD Bio Limited CEO Dr. Ethan Shen Details Strategic Roadmap for Integrated Oncology Ecosystem
Mar 25
YD Bio Limited Announces Strategic Partnership with YC Biotech Co., Ltd. to Establish a Taiwan-U.S. Dual-Core Regulatory Platform
Feb 27
YD Bio Limited Enters into Binding Letter of Intent to Acquire Safe Save Medical Cell Sciences & Technology Co., Ltd., Bolstering Leadership in Advanced Immunocell Therapy
Feb 5
bottom of page
